Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 2B
Study Completion Date
October 2008
NCT00301821Uploaded 09-11-2019
Access via NCI by Request
PDS UID: nci-data-372
A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
Files: NCT00301821-D2
Data DictionaryNCT00301821-D2-Data-Dictionary_0.pdf
Files: NCT00301821-D1
Data DictionaryNCT00301821-D1-Data-Dictionary_0.pdf